サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：シングルユースバイオリアクター市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
市場調査レポート
商品コード
1326512

シングルユースバイオリアクター市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年

Single-Use Bioreactors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Type, By Type of Cell, By Molecule, By Application, By Usage, By End User, By Region and Competition
出版日: | 発行: TechSci Research | ページ情報: 英文 116 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

シングルユースバイオリアクター市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年08月01日
発行: TechSci Research
ページ情報: 英文 116 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のシングルユースバイオリアクター市場は、予測期間2024-2028年に安定したCAGRの成長が見込まれます。

これは、研究開発（R&D）活動、共同研究、戦略的パートナーシップの増加、新しいワクチンや治療薬、慢性疾患や感染症に対する需要の高まりが背景にあります。また、モノクローナル抗体の開発が進むことで、製造施設に使用されるSUBの需要が増加し、同分野の成長を促進すると予想されています。2022年1月、HaemaLogiX Ltd（HaemaLogiX）とLonzaは、HaemaLogiXの主要な多発性骨髄腫治療薬候補であるKappaMabの次の臨床バッチ（cGMP）を製造する契約を締結しました。KappaMabはモノクローナル抗体で、κ骨髄腫抗原（KMA）と呼ばれ、骨髄腫がん細胞には存在するが、正常な形質細胞には存在しない細胞表面標的に結合します。

バイオ医薬品に対する需要の増加

バイオ医薬品は世界のシングルユースバイオリアクター市場の成長を牽引する重要な役割を担っています。バイオ医薬品とは、細菌、酵母、哺乳類細胞などの生体を用いて製造される医薬品やワクチンのことです。シングルユースバイオリアクターは、その費用対効果、効率性、柔軟性により、これらのバイオ医薬品の生産に広く使用されています。バイオ医薬品に対する需要の増加は、シングルユースバイオリアクター市場の主要促進要因の一つです。バイオ医薬品は、様々な疾患に対して的を絞った個別化治療を提供するため、現代医療の重要な構成要素となっています。世界のバイオ医薬品市場は、高齢化、慢性疾患の増加、革新的な標的治療の必要性などの要因によって、著しい成長が見込まれています。シングルユースバイオリアクターには、従来のステンレス製バイオリアクターに比べて、資本コストや運用コストの削減、交差汚染のリスクの低減、柔軟性の向上など、いくつかの利点があります。これらの利点により、シングルユースバイオリアクターは、特に少量バッチや臨床試験用のバイオ医薬品を製造するための魅力的な選択肢となっています。バイオ医薬品業界は、高密度細胞培養や連続製造などの新しいバイオプロセス技術を採用しており、柔軟で効率的なバイオリアクターを必要としています。シングルユースバイオリアクターは、変化するプロセス要件に適応できるため、こうした新技術に最適です。

シングルユースバイオリアクターの費用対効果と効率性

費用対効果と効率性は、世界のシングルユースバイオリアクター市場の成長を促進する主な要因です。シングルユースバイオリアクターは、従来のステンレス製バイオリアクターに比べて、コストと効率の面でいくつかの利点があります。シングルユースバイオリアクターの主な利点の一つは、資本コストが低いことです。従来のステンレス製バイオリアクターは、インフラや設備に多額の先行投資が必要であったのに対し、シングルユースバイオリアクターは設備投資が大幅に少なくて済みます。このため、シングルユースバイオリアクターは、中小企業や研究開発目的の企業にとって、資本コストを低減するための魅力的な選択肢となっています。シングルユースバイオリアクターは、従来のバイオリアクターに比べて運用コストが低いです。バッグ、フィルター、センサーなどのシングルユースコンポーネントの使用により、時間とコストのかかる洗浄や滅菌の必要性が減少します。これにより、バッチ間の二次汚染のリスクが軽減され、より高品質で安定した製品が保証されます。シングルユースバイオリアクターは柔軟性が高く、効率の向上につながります。迅速かつ簡単にセットアップできるため、製品のターンアラウンド時間を短縮することができます。シングルユースバイオリアクターは、プロセス要件の変更への適応性が高く、小規模生産だけでなく、研究開発にも理想的です。

個別化医療への注目の高まり

個別化医療は、世界のシングルユースバイオリアクター市場成長の主要な促進要因です。個別化医療とは、患者の治療計画を立てる際に、遺伝子、環境、ライフスタイルの個人差を考慮するヘルスケアへのアプローチです。このアプローチでは、バイオ医薬品とシングルユースバイオリアクターを使用して実現できる、標的を絞った個別化治療の生産が必要です。シングルユースバイオリアクターの使用により、個別化医療の基礎となるバイオ医薬品をより効率的かつコスト効率よく生産することができます。シングルユースバイオリアクターは、従来のステンレス製バイオリアクターに比べて、柔軟性、効率性、拡張性の面でいくつかの利点があり、標的治療や個別化治療の生産に理想的です。

バイオプロセス技術の進歩

技術と研究の進歩は、世界のシングルユースバイオリアクター市場成長の主要な促進要因です。バイオ医薬品産業が進化と拡大を続ける中、より効率的でコスト効率の高いバイオプロセシング・ソリューションへのニーズが高まっています。新素材や製造プロセスの開発により、より高いレベルの性能、信頼性、拡張性を提供する、より高度なシングルユースバイオリアクターの生産が進んでいます。例えば、ポリエチレンやポリプロピレンなどの先端ポリマーの使用により、より耐久性に優れ、幅広い化学物質や温度範囲に耐性を持つシングルユースバイオリアクターが製造されるようになりました。さらに、自動化とプロセス制御の進歩により、バイオプロセス操作がより正確かつ効率的になり、シングルユースバイオリアクターの需要がさらに高まっています。自動化技術は、汚染のリスクを低減し、オペレーターのミスを最小限に抑え、バイオプロセス操作のスピードと精度を高めるのに役立ちます。より洗練されたセンサーと分析ツールの開発により、バイオプロセスのより詳細なモニタリングと制御が可能になっています。その結果、プロセス効率の改善、製品収率の向上、コスト削減につながっています。バイオ医薬品の新たな用途や利用法が発見され続けるにつれ、より高度なシングルユースバイオリアクターの需要は拡大すると予想されます。このような進歩は、バイオ医薬品業界のニーズを満たす、より効率的で費用対効果の高いバイオプロセシング・ソリューションを提供し、世界のシングルユースバイオリアクター市場の革新と成長を促進し続けるでしょう。

バイオ医薬品産業への資金援助の拡大

世界シングルユースバイオリアクター市場の成長には、政府支援の拡大が大きく影響しています。世界中の政府がバイオ医薬品産業の重要性を認識するようになっており、シングルユースバイオリアクターなどのバイオプロセス技術が新薬などのバイオ医薬品の開発・生産に重要な役割を果たしています。各国政府は、研究開発への資金提供、税制優遇措置、規制支援など、いくつかの方法でシングルユースバイオリアクター市場の成長を支援しており、これが予測期間中の市場成長をさらに後押しすることになります。例えば米国では、国立衛生研究所（NIH）やバイオメディカル先端研究開発局（BARDA）が、シングルユースバイオリアクターを含む新しいバイオプロセス技術の研究開発に資金を提供しています。政府は、バイオ医薬品の安全性と有効性を規制する上で重要な役割を果たしており、その製造に使用される技術は、バイオ医薬品製造への採用を加速し、長年にわたって市場の成長を促進します。

利用可能なカスタマイズ

所定の市場データを用いて、TechSci Researchは企業固有のニーズに応じたカスタマイズを提供します。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 シングルユースバイオリアクターの世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • 細胞タイプ別
    • 分子別
    • 用途別
    • 使用法別
    • エンドユーザー別
    • 地域別
    • 企業別
  • 市場マップ
    • 製品別
    • タイプ別
    • 細胞タイプ別
    • 分子別
    • 用途別
    • 使用法別
    • エンドユーザー別
    • 地域別

第6章 北米のシングルユースバイオリアクター市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • 細胞タイプ別
    • 分子別
    • 用途別
    • 使用法別
    • エンドユーザー別
    • 国別
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州のシングルユースバイオリアクター市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • 細胞タイプ別
    • 分子別
    • 用途別
    • 使用法別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋のシングルユースバイオリアクター市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • 細胞タイプ別
    • 分子別
    • 用途別
    • 使用法別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米のシングルユースバイオリアクターの市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • 細胞タイプ別
    • 分子別
    • 用途別
    • 使用法別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのシングルユースバイオリアクター市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • 細胞タイプ別
    • 分子別
    • 用途別
    • 使用法別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
    • ラボの自動化に対する需要の高まり
    • バイオバンクによるラボインフォマティクスの採用拡大
    • 技術的に高度なソフトウェアサービスのイントロダクションの成長
  • 課題
    • ラボインフォマティクスの統合基準の欠如
    • 厳しい規制

第12章 市場動向と発展

  • 最近の発展
  • 合併と買収
  • 製品上市

第13章 シングルユースバイオリアクターの世界市場SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials（As Reported）
  • Key Personnel
  • SWOT Analysis
    • ABEC,INC.
    • Able Corporation & Biott Corporation.
    • BBI-Biotech Gmbh.
    • Cellexus Biosystems PLC.
    • Celltainer Biotech BV.
    • Danaher Corp.
    • Distek Inc.
    • Eppendorf AG.
    • G&G Technologies, Inc.
    • Getinge AB.

第16章 戦略的提言

目次
Product Code: 15169

Global Single-Use Bioreactors Market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. This can be ascribed to the increasing research and development (R&D) activities, collaborations, and strategic partnerships, along with soaring demand for new vaccines, therapeutics, and rising chronic and infectious diseases. Also, the growing development of monoclonal antibodies is anticipated to create demand for SUBs used for manufacturing facilities, thereby expected to drive segment growth. In January 2022, HaemaLogiX Ltd (HaemaLogiX) and Lonza entered into an agreement for manufacturing the next clinical batch (cGMP) of HaemaLogiX's lead multiple myeloma drug candidate and KappaMab, which is a monoclonal antibody and binds to a cell surface target which is called as kappa myeloma antigen (KMA) and found on myeloma cancer cells and not on normal plasma cells.

Increasing demand for biopharmaceuticals

Biopharmaceuticals play a significant role in driving the growth of the Global Single-Use Bioreactors Market. Biopharmaceuticals are drugs and vaccines that are produced using living organisms such as bacteria, yeast, or mammalian cells. Single-use bioreactors are widely used in the production of these biopharmaceuticals due to their cost-effectiveness, efficiency, and flexibility. The increasing demand for biopharmaceuticals is one of the key drivers of the Single-Use Bioreactors Market. Biopharmaceuticals have become an important component of modern medicine, as they offer targeted and personalized treatments for various diseases. The Global Biopharmaceuticals Market is expected to grow at a significant rate, driven by factors such as an aging population, increasing prevalence of chronic diseases, and the need for innovative and targeted therapies. Single-use bioreactors offer several advantages over traditional stainless-steel bioreactors, such as lower capital and operational costs, reduced risk of cross-contamination, and greater flexibility. These advantages make single-use bioreactors an attractive option to produce biopharmaceuticals, particularly for smaller batches and clinical trials. The biopharmaceutical industry is adopting new bioprocessing technologies, such as high-density cell cultures and continuous manufacturing, which require flexible and efficient bioreactors. Single-use bioreactors can adapt to changing process requirements, making them ideal for these new technologies.

Cost-effectiveness and efficiency of single-use bioreactors

Cost-effectiveness and efficiency are key factors driving the growth of the Global Single-Use Bioreactors Market. Single-use bioreactors offer several advantages over traditional stainless-steel bioreactors in terms of cost and efficiency. One of the primary advantages of single-use bioreactors is their lower capital cost. Traditional stainless-steel bioreactors require significant upfront capital investments in infrastructure and equipment, whereas single-use bioreactors require much less capital investment. This makes single-use bioreactors an attractive option for small and medium-sized companies, as well as for research and development purposes to lower capital costs; single-use bioreactors offer lower operational costs compared to traditional bioreactors. The use of single-use components, such as bags, filters, and sensors, reduces the need for cleaning and sterilization, which can be time-consuming and costly. This reduces the risk of cross-contamination between batches, ensuring higher quality and more consistent products. Single-use bioreactors offer greater flexibility, which can lead to increased efficiency. They can be quickly and easily set up, allowing for faster product turnaround times. Single-use bioreactors are more adaptable to changes in process requirements, making them ideal for research and development, as well as for small-scale production.

Growing focus on personalized medicine

Personalized medicine is a major driver of the growth of the Global Single-Use Bioreactors Market. Personalized medicine is an approach to healthcare that considers individual variability in genes, environment, and lifestyle when designing treatment plans for patients. This approach requires the production of targeted and individualized therapies, which can be achieved using biopharmaceuticals and single-use bioreactors. The use of single-use bioreactors allows for more efficient and cost-effective production of biopharmaceuticals, which are the foundation of personalized medicine. Single-use bioreactors offer several advantages over traditional stainless-steel bioreactors in terms of flexibility, efficiency, and scalability, making them ideal for producing targeted and personalized therapies.

Single-use bioreactors are particularly well-suited to produce smaller batches of biopharmaceuticals, which are often required for personalized medicine. They are ideal for research and development purposes, as they allow for rapid and cost-effective testing of new therapies. The demand for personalized medicine is expected to grow in the coming years, driven by factors such as an aging population, increasing prevalence of chronic diseases, and advances in genomics and proteomics. This growth is expected to fuel the demand for biopharmaceuticals and single-use bioreactors, as personalized medicine requires the production of targeted and individualized therapies.

Advancements in bioprocessing technology

Advancements in technology and research are key drivers of the growth of the Global Single-Use Bioreactors Market. As the biopharmaceutical industry continues to evolve and expand, there is a growing need for more efficient and cost-effective bioprocessing solutions. The development of new materials and manufacturing processes has led to the production of more advanced single-use bioreactors that offer higher levels of performance, reliability, and scalability. For example, the use of advanced polymers such as polyethylene and polypropylene has led to the production of single-use bioreactors that are more durable and resistant to a wider range of chemicals and temperature ranges. In addition, advancements in automation and process control have led to more precise and efficient bioprocessing operations, further driving the demand for single-use bioreactors. Automation technology can help to reduce the risk of contamination, minimize operator error, and increase the speed and accuracy of bioprocessing operations. The development of more sophisticated sensors and analytical tools has allowed for more detailed monitoring and control of bioprocesses. This has led to improved process efficiency, higher product yields, and reduced costs. As research continues to uncover new applications and uses for biopharmaceuticals, the demand for more advanced single-use bioreactors is expected to grow. These advancements will continue to drive innovation and growth in the Global Single-Use Bioreactors Market, providing more efficient and cost-effective bioprocessing solutions to meet the needs of the biopharmaceutical industry.

Growing funding for the biopharmaceutical industry

Growing government support plays a significant impact in the growth of the Global Single-Use Bioreactors Market. Governments around the world are increasingly recognizing the importance of the biopharmaceutical industry and the role of these bioprocessing technologies, such as single-use bioreactors, play an important role in the development and production of biopharmaceutical products such as novel drugs. Governments provide support for the growth of the single-use bioreactors market in several ways, including funding for research and development, tax incentives, and regulatory support which will further drive the growth of the market during the forecast period. For example, in the United States, the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) provide funding for research and development of new bioprocessing technologies, including single-use bioreactors. Governments play a crucial role in regulating the safety and efficacy of biopharmaceutical products, and the technologies used to produce them will accelerate their adoption in biopharmaceutical manufacturing and propel the growth of the market over the years.

Recent Development

  • In March 2022, Sartorius AG announced the launch of its new single-use bioreactor system, BIOSTAT STR® 1000. The system was designed to meet the growing demand for large-scale bioprocessing and offers advanced automation and control features.
  • In January 2022, GE Healthcare Life Sciences announced the acquisition of Univercells Technologies, a provider of innovative bioprocessing solutions. The acquisition is expected to expand GE Healthcare's offerings in the single-use bioreactors market and enhance its position in the biopharmaceutical industry.
  • In December 2021, Thermo Fisher Scientific announced the launch of its new single-use bioreactor, the HyPerforma™ Single-Use Bioreactor (SUB). The system is designed to provide high yields and process efficiencies with improved flexibility and scalability.
  • In November 2021, Merck KGaA announced the expansion of its single-use manufacturing facility in the United States. The expansion is expected to increase Merck's capacity to produce single-use bioreactors and support the growing demand for biopharmaceutical products.
  • In September 2021, Pall Corporation announced the launch of its new single-use bioreactor, the Allegro™ STR 400. The system offers advanced automation and control features, as well as improved flexibility and scalability for bioprocessing operations.

Market Segmentation

Global Single-Use Bioreactors market can be segmented by product, type, type of cell, molecule, application, usage, end user, and by region. Based on product, the market can be segmented into Single-use bioreactor systems, Single-use media bags, Single-use filtration assemblies, and other products. Based on type, the market can be segmented into Stirred tank SUB, Wave induced SUB, Bubble Column SUB, and Other SUB. Based on the type of cell, the market can be differentiated into Mammalian Cell, Bacterial Cell, Yeast Cell, and Other Cells. Based on molecules, the market can be grouped into Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, and Other molecules. Based on application, the market can be segmented into Research and Development, Bioproduction. Based on usage, the market can be differentiated into Lab scale production, Pilot scale production, and large scale production. Based on end users, the market can be grouped into Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, and Academic and Research Institutes.

Market Players

ABEC, INC., Able Corporation & Biott Corporation., BBI-Biotech Gmbh., Cellexus Biosystems PLC., Celltainer Biotech BV., Danaher Corp., Distek Inc., Eppendorf AG., G&G Technologies, Inc., Getinge AB are some of the leading players operating in the Global Single-Use Bioreactors Market.

Report Scope:

In this report, the Global Single-Use Bioreactors market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Single-Use Bioreactors Market, By Product:

  • Single-use bioreactor systems
  • Single use media bags
  • Single use filtration assemblies
  • other products

Single-Use Bioreactors Market, By Type:

  • Stirred tank SUB.
  • Wave-induced SUB.
  • Bubble Column SUB
  • Other SUB

Single-Use Bioreactors Market, By Type of Cell:

  • Mammalian Cell
  • Bacterial Cell
  • Yeast Cell
  • Other Cells

Single-Use Bioreactors Market, By Molecule:

  • Monoclonal Antibodies
  • Vaccines
  • Gene Modified Cells
  • Stem Cells
  • Other molecules

Single-Use Bioreactors Market, By Application:

  • Research and Development
  • Bioproduction

Single-Use Bioreactors Market, By Usage:

  • Lab-scale production
  • Pilot-scale production
  • large scale production

Single-Use Bioreactors Market, By End User:

  • Pharmaceutical and Biopharmaceutical companies
  • CROSs & CMOS
  • Academic and Research Institutes

Single-Use Bioreactors Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Single-Use Bioreactors Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Single-Use Bioreactors Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 5.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 5.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 5.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 5.2.5. By Application (Research and Development, Bioproduction)
    • 5.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 5.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 5.2.8. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.9. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Product
    • 5.3.2 By Type
    • 5.3.3 By Type of Cell
    • 5.3.4 By Molecule
    • 5.3.5 By Application
    • 5.3.6 By Usage
    • 5.3.7 By End User
    • 5.3.5 By Region

6. North America Single-Use Bioreactors Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 6.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 6.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 6.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 6.2.5. By Application (Research and Development, Bioproduction)
    • 6.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 6.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 6.2.8. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Single-Use Bioreactors Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Type of Cell
        • 6.3.1.2.4. By Molecule
        • 6.3.1.2.5. By Application
        • 6.3.1.2.6. By Usage
        • 6.3.1.2.7. By End User
    • 6.3.2. Canada Single-Use Bioreactors Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Type of Cell
        • 6.3.2.2.4. By Molecule
        • 6.3.2.2.5. By Application
        • 6.3.2.2.6. By Usage
        • 6.3.2.2.7. By End User
    • 6.3.3. Mexico Single-Use Bioreactors Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Type of Cell
        • 6.3.3.2.4. By Molecule
        • 6.3.3.2.5. By Application
        • 6.3.3.2.6. By Usage
        • 6.3.3.2.7. By End User

7. Europe Single-Use Bioreactors Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 7.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 7.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 7.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 7.2.5. By Application (Research and Development, Bioproduction)
    • 7.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 7.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 7.2.8. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Single-Use Bioreactors Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Type of Cell
        • 7.3.1.2.4. By Molecule
        • 7.3.1.2.5. By Application
        • 7.3.1.2.6. By Usage
        • 7.3.1.2.7. By End User
    • 7.3.2. Germany Single-Use Bioreactors Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Type of Cell
        • 7.3.2.2.4. By Molecule
        • 7.3.2.2.5. By Application
        • 7.3.2.2.6. By Usage
        • 7.3.2.2.7. By End User
    • 7.3.3. United Kingdom Single-Use Bioreactors Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Type of Cell
        • 7.3.3.2.4. By Molecule
        • 7.3.3.2.5. By Application
        • 7.3.3.2.6. By Usage
        • 7.3.3.2.7. By End User
    • 7.3.4. Italy Single-Use Bioreactors Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Type of Cell
        • 7.3.4.2.4. By Molecule
        • 7.3.4.2.5. By Application
        • 7.3.4.2.6. By Usage
        • 7.3.4.2.7. By End User
    • 7.3.5. Spain Single-Use Bioreactors Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Type of Cell
        • 7.3.5.2.4. By Molecule
        • 7.3.5.2.5. By Application
        • 7.3.5.2.6. By Usage
        • 7.3.5.2.7. By End User

8. Asia-Pacific Single-Use Bioreactors Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 8.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 8.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 8.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 8.2.5. By Application (Research and Development, Bioproduction)
    • 8.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 8.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 8.2.8. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Single-Use Bioreactors Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Type of Cell
        • 8.3.1.2.4. By Molecule
        • 8.3.1.2.5. By Application
        • 8.3.1.2.6. By Usage
        • 8.3.1.2.7. By End User
    • 8.3.2. India Single-Use Bioreactors Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Type of Cell
        • 8.3.2.2.4. By Molecule
        • 8.3.2.2.5. By Application
        • 8.3.2.2.6. By Usage
        • 8.3.2.2.7. By End User
    • 8.3.3. Japan Single-Use Bioreactors Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Type of Cell
        • 8.3.3.2.4. By Molecule
        • 8.3.3.2.5. By Application
        • 8.3.3.2.6. By Usage
        • 8.3.3.2.7. By End User
    • 8.3.4. South Korea Single-Use Bioreactors Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Type of Cell
        • 8.3.4.2.4. By Molecule
        • 8.3.4.2.5. By Application
        • 8.3.4.2.6. By Usage
        • 8.3.4.2.7. By End User
    • 8.3.5. Australia Single-Use Bioreactors Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Type of Cell
        • 8.3.5.2.4. By Molecule
        • 8.3.5.2.5. By Application
        • 8.3.5.2.6. By Usage
        • 8.3.5.2.7. By End User

9. South America Single-Use Bioreactors Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 9.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 9.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 9.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 9.2.5. By Application (Research and Development, Bioproduction)
    • 9.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 9.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 9.2.8. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Single-Use Bioreactors Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Type of Cell
        • 9.3.1.2.4. By Molecule
        • 9.3.1.2.5. By Application
        • 9.3.1.2.6. By Usage
        • 9.3.1.2.7. By End User
    • 9.3.2. Argentina Single-Use Bioreactors Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Type of Cell
        • 9.3.2.2.4. By Molecule
        • 9.3.2.2.5. By Application
        • 9.3.2.2.6. By Usage
        • 9.3.2.2.7. By End User
    • 9.3.3. Colombia Single-Use Bioreactors Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Type of Cell
        • 9.3.3.2.4. By Molecule
        • 9.3.3.2.5. By Application
        • 9.3.3.2.6. By Usage
        • 9.3.3.2.7. By End User

10. Middle East and Africa Single-Use Bioreactors Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 10.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 10.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 10.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 10.2.5. By Application (Research and Development, Bioproduction)
    • 10.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 10.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 10.2.8. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Single-Use Bioreactors Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Type of Cell
        • 10.3.1.2.4. By Molecule
        • 10.3.1.2.5. By Application
        • 10.3.1.2.6. By Usage
        • 10.3.1.2.7. By End User
    • 10.3.2. Saudi Arabia Single-Use Bioreactors Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Type of Cell
        • 10.3.2.2.4. By Molecule
        • 10.3.2.2.5. By Application
        • 10.3.2.2.6. By Usage
        • 10.3.2.2.7. By End User
    • 10.3.3. UAE Single-Use Bioreactors Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Type of Cell
        • 10.3.3.2.4. By Molecule
        • 10.3.3.2.5. By Application
        • 10.3.3.2.6. By Usage
        • 10.3.3.2.7. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1 Growing demand for lab automation activities
    • 11.1.2 Growing adoption of lab informatics by biobanks
    • 11.1.3 Growing introduction of technologically advanced software services
  • 11.2. Challenges
    • 11.2.1 Lack of integration standards for laboratory informatics
    • 11.2.2 Stringent Regulations

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Single-Use Bioreactors Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 ABEC,INC.
    • 15.6.2 Able Corporation & Biott Corporation.
    • 15.6.3 BBI-Biotech Gmbh.
    • 15.6.4 Cellexus Biosystems PLC.
    • 15.6.5 Celltainer Biotech BV.
    • 15.6.6 Danaher Corp.
    • 15.6.7 Distek Inc.
    • 15.6.8 Eppendorf AG.
    • 15.6.9 G&G Technologies, Inc.
    • 15.6.10 Getinge AB.

16. Strategic Recommendations